Skip to main content
OpenTrials

Clinical trial condition

Hypertension, Pulmonary

Explore clinical trials studying Hypertension, Pulmonary. Study availability and eligibility vary by location and protocol.

120 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Hypertension, Pulmonary trial results

Completed

Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

NCT01462565

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • GSK Investigational Site Miami Beach, Florida, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT01178073

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
View all 143 locations
View Trial Details
Completed

A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice

NCT02545465

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • Many Locations, Belgium
  • Many Locations, Canada
  • Many Locations, Colombia
  • Many Locations, Germany
View Trial Details
Completed

An Observational Study For Ambrisentan

NCT00679224

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
Locations
  • GSK Investigational Site Darlinghurst, New South Wales, Australia
  • GSK Investigational Site Chermside, Queensland, Australia
  • GSK Investigational Site Melbourne, Victoria, Australia
  • GSK Investigational Site Brussels, Belgium
View all 112 locations
View Trial Details

Related conditions